Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 381 | $86,679,447 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 05 Mar 2025 16:22 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 03 Mar 2025 | Sale | 204 | 242.37 | 49,443 | D |
| 05 Mar 2025 16:22 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 03 Mar 2025 | Sale | 224 | 243.36 | 54,513 | D |
| 05 Mar 2025 16:22 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 03 Mar 2025 | Sale | 151 | 244.41 | 36,906 | D |
| 05 Mar 2025 16:22 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 03 Mar 2025 | Sale | 111 | 245.26 | 27,224 | D |
| 05 Mar 2025 16:22 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 03 Mar 2025 | Sale | 45 | 246.18 | 11,078 | D |
| 05 Mar 2025 16:22 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 03 Mar 2025 | Sale | 4 | 247.35 | 989 | D |
| 05 Mar 2025 16:22 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 03 Mar 2025 | Sale | 1 | 248.36 | 248 | D |
| 05 Mar 2025 16:22 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 03 Mar 2025 | Sale | 465 | 242.69 | 112,851 | D |
| 05 Mar 2025 16:22 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 03 Mar 2025 | Sale | 487 | 243.94 | 118,799 | D |
| 05 Mar 2025 16:22 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 03 Mar 2025 | Sale | 219 | 245.3 | 53,721 | D |
| 05 Mar 2025 16:22 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 04 Mar 2025 | Sale | 121 | 239.24 | 28,948 | D |
| 05 Mar 2025 16:22 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 04 Mar 2025 | Sale | 328 | 240.95 | 79,032 | D |
| 05 Mar 2025 16:22 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 04 Mar 2025 | Sale | 324 | 241.68 | 78,304 | D |
| 05 Mar 2025 16:22 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 04 Mar 2025 | Sale | 71 | 242.93 | 17,248 | D |
| 05 Mar 2025 16:22 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 03 Mar 2025 | Sale | 131 | 242.37 | 31,750 | D |
| 05 Mar 2025 16:22 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 03 Mar 2025 | Sale | 142 | 243.36 | 34,557 | D |
| 05 Mar 2025 16:22 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 03 Mar 2025 | Sale | 96 | 244.41 | 23,463 | D |
| 05 Mar 2025 16:22 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 03 Mar 2025 | Sale | 70 | 245.26 | 17,168 | D |
| 05 Mar 2025 16:22 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 03 Mar 2025 | Sale | 29 | 246.18 | 7,139 | D |
| 05 Mar 2025 16:22 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 03 Mar 2025 | Sale | 3 | 247.35 | 742 | D |
| 05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 03 Mar 2025 | Sale | 213 | 242.37 | 51,625 | D |
| 05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 03 Mar 2025 | Sale | 235 | 243.36 | 57,190 | D |
| 05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 03 Mar 2025 | Sale | 158 | 244.41 | 38,617 | D |
| 05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 03 Mar 2025 | Sale | 116 | 245.26 | 28,450 | D |
| 05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 03 Mar 2025 | Sale | 48 | 246.18 | 11,817 | D |
| 05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 03 Mar 2025 | Sale | 5 | 247.35 | 1,237 | D |
| 05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 03 Mar 2025 | Sale | 1 | 248.36 | 248 | D |
| 05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 03 Mar 2025 | Sale | 583 | 243.13 | 141,745 | D |
| 05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 03 Mar 2025 | Sale | 273 | 244.43 | 66,729 | D |
| 05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 03 Mar 2025 | Sale | 117 | 245.53 | 28,727 | D |
| 05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 04 Mar 2025 | Sale | 147 | 239.25 | 35,170 | D |
| 05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 04 Mar 2025 | Sale | 343 | 240.92 | 82,636 | D |
| 05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 04 Mar 2025 | Sale | 198 | 241.6 | 47,837 | D |
| 05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 04 Mar 2025 | Sale | 120 | 242.7 | 29,124 | D |
| 05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 03 Mar 2025 | Sale | 350 | 242.37 | 84,830 | D |
| 05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 03 Mar 2025 | Sale | 382 | 243.36 | 92,964 | D |
| 05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 03 Mar 2025 | Sale | 258 | 244.41 | 63,058 | D |
| 05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 03 Mar 2025 | Sale | 189 | 245.26 | 46,354 | D |
| 05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 03 Mar 2025 | Sale | 77 | 246.18 | 18,956 | D |
| 05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 03 Mar 2025 | Sale | 7 | 247.35 | 1,731 | D |
| 05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 03 Mar 2025 | Sale | 1 | 248.36 | 248 | D |
| 05 Mar 2025 16:20 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 03 Mar 2025 | Sale | 1,068 | 242.37 | 258,851 | D |
| 05 Mar 2025 16:20 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 03 Mar 2025 | Sale | 1,173 | 243.36 | 285,461 | D |
| 05 Mar 2025 16:20 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 03 Mar 2025 | Sale | 791 | 244.41 | 193,328 | D |
| 05 Mar 2025 16:20 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 03 Mar 2025 | Sale | 580 | 245.26 | 142,251 | D |
| 05 Mar 2025 16:20 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 03 Mar 2025 | Sale | 238 | 246.18 | 58,591 | D |
| 05 Mar 2025 16:20 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 03 Mar 2025 | Sale | 23 | 247.35 | 5,689 | D |
| 05 Mar 2025 16:20 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 03 Mar 2025 | Sale | 4 | 248.36 | 993 | D |
| 03 Mar 2025 16:32 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 28 Feb 2025 | Sale | 158 | 236.51 | 37,369 | D |
| 03 Mar 2025 16:32 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 28 Feb 2025 | Sale | 123 | 238.33 | 29,315 | D |
| 03 Mar 2025 16:32 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 28 Feb 2025 | Sale | 127 | 239.18 | 30,376 | D |
| 03 Mar 2025 16:32 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 28 Feb 2025 | Sale | 284 | 240.32 | 68,251 | D |
| 03 Mar 2025 16:32 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 28 Feb 2025 | Sale | 461 | 241.51 | 111,336 | D |
| 03 Mar 2025 16:32 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 28 Feb 2025 | Sale | 1,093 | 242.44 | 264,987 | D |
| 03 Mar 2025 16:32 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 28 Feb 2025 | Sale | 440 | 243.23 | 107,021 | D |
| 03 Mar 2025 16:32 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 28 Feb 2025 | Sale | 214 | 244.11 | 52,240 | D |
| 03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2025 | Sale | 42 | 236.51 | 9,933 | D |
| 03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2025 | Sale | 34 | 238.33 | 8,103 | D |
| 03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2025 | Sale | 35 | 239.18 | 8,371 | D |
| 03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2025 | Sale | 78 | 240.32 | 18,745 | D |
| 03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2025 | Sale | 127 | 241.51 | 30,672 | D |
| 03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2025 | Sale | 300 | 242.44 | 72,732 | D |
| 03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2025 | Sale | 121 | 243.23 | 29,431 | D |
| 03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2025 | Sale | 59 | 244.11 | 14,402 | D |
| 03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 28 Feb 2025 | Sale | 28 | 236.51 | 6,622 | D |
| 03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 28 Feb 2025 | Sale | 22 | 238.33 | 5,243 | D |
| 03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 28 Feb 2025 | Sale | 23 | 239.18 | 5,501 | D |
| 03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 28 Feb 2025 | Sale | 50 | 240.32 | 12,016 | D |
| 03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 28 Feb 2025 | Sale | 82 | 241.51 | 19,804 | D |
| 03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 28 Feb 2025 | Sale | 192 | 242.44 | 46,548 | D |
| 03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 28 Feb 2025 | Sale | 78 | 243.23 | 18,972 | D |
| 03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 28 Feb 2025 | Sale | 38 | 244.11 | 9,276 | D |
| 03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Feb 2025 | Sale | 51 | 236.51 | 12,062 | D |
| 03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Feb 2025 | Sale | 40 | 238.33 | 9,533 | D |
| 03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Feb 2025 | Sale | 41 | 239.18 | 9,806 | D |
| 03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Feb 2025 | Sale | 91 | 240.32 | 21,869 | D |
| 03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Feb 2025 | Sale | 149 | 241.51 | 35,985 | D |
| 03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Feb 2025 | Sale | 352 | 242.44 | 85,339 | D |
| 03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Feb 2025 | Sale | 142 | 243.23 | 34,539 | D |
| 03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Feb 2025 | Sale | 69 | 244.11 | 16,844 | D |
| 03 Mar 2025 16:30 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 28 Feb 2025 | Sale | 27 | 236.51 | 6,386 | D |
| 03 Mar 2025 16:30 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 28 Feb 2025 | Sale | 21 | 238.33 | 5,005 | D |
| 03 Mar 2025 16:30 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 28 Feb 2025 | Sale | 22 | 239.18 | 5,262 | D |
| 03 Mar 2025 16:30 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 28 Feb 2025 | Sale | 48 | 240.32 | 11,535 | D |
| 03 Mar 2025 16:30 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 28 Feb 2025 | Sale | 79 | 241.51 | 19,079 | D |
| 03 Mar 2025 16:30 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 28 Feb 2025 | Sale | 187 | 242.44 | 45,336 | D |
| 03 Mar 2025 16:30 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 28 Feb 2025 | Sale | 75 | 243.23 | 18,242 | D |
| 03 Mar 2025 16:30 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 28 Feb 2025 | Sale | 37 | 244.11 | 9,032 | D |
| 18 Feb 2025 16:49 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 14 Feb 2025 | Sale | 271 | 252.5 | 68,428 | D |
| 18 Feb 2025 16:49 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 14 Feb 2025 | Sale | 300 | 253.37 | 76,011 | D |
| 18 Feb 2025 16:49 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 14 Feb 2025 | Sale | 201 | 254.35 | 51,124 | D |
| 18 Feb 2025 16:49 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 14 Feb 2025 | Sale | 85 | 255.56 | 21,723 | D |
| 18 Feb 2025 16:49 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 14 Feb 2025 | Sale | 98 | 256.29 | 25,116 | D |
| 18 Feb 2025 16:49 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 14 Feb 2025 | Sale | 47 | 257.51 | 12,103 | D |
| 18 Feb 2025 16:49 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 14 Feb 2025 | Sale | 59 | 258.07 | 15,226 | D |
| 18 Feb 2025 16:49 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 14 Feb 2025 | Sale | 21 | 259.72 | 5,454 | D |
| 18 Feb 2025 16:49 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 14 Feb 2025 | Sale | 38 | 260.57 | 9,902 | D |
| 18 Feb 2025 16:49 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 14 Feb 2025 | Sale | 47 | 261.45 | 12,288 | D |
| 18 Feb 2025 16:49 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 14 Feb 2025 | Sale | 21 | 263.33 | 5,530 | D |
| 18 Feb 2025 16:49 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 14 Feb 2025 | Sale | 25 | 264.87 | 6,622 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)